lestaurtinib has been researched along with Neuroblastoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodeur, GM; Choi, JH; Croucher, JL; Gaonkar, KS; Golden, RL; Guan, P; Iyer, R; Kolla, V; Macfarland, SP; Naraparaju, K; Nguyen, F; Raman, P; Tetri, LH | 1 |
| Balamuth, N; Brodeur, GM; Evans, AE; Ho, R; Iyer, R; Maris, JM; Minturn, JE; Qi, X; Zhao, H | 1 |
| Bensen-Kennedy, D; Brodeur, GM; Evans, AE; Groshen, S; Hellriegel, ET; Maris, JM; Matthay, KK; Minturn, JE; Park, JR; Shusterman, S; Villablanca, JG; Yanik, GA | 1 |
| Adamson, PC; Brodeur, GM; Maris, JM; Minturn, JE; Norris, RE | 1 |
1 trial(s) available for lestaurtinib and Neuroblastoma
| Article | Year |
|---|---|
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.
Topics: Adolescent; Antineoplastic Agents; Carbazoles; Child; Child, Preschool; Dose-Response Relationship, Drug; Furans; Humans; Maximum Tolerated Dose; Neuroblastoma; Phosphorylation; Protein Kinase Inhibitors; Receptor, trkB; Treatment Outcome; Young Adult | 2011 |
3 other study(ies) available for lestaurtinib and Neuroblastoma
| Article | Year |
|---|---|
RET receptor expression and interaction with TRK receptors in neuroblastomas.
Topics: Carbazoles; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Furans; Gene Expression Regulation, Neoplastic; Guanine Nucleotide Exchange Factors; Humans; Neuroblastoma; Phosphorylation; Proto-Oncogene Proteins c-ret; ras Guanine Nucleotide Exchange Factors; Receptor, trkA; Signal Transduction; Up-Regulation | 2020 |
Lestaurtinib enhances the antitumor efficacy of chemotherapy in murine xenograft models of neuroblastoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Carbazoles; Cyclophosphamide; Dacarbazine; Enzyme Activation; Furans; Humans; Irinotecan; Mice; Mice, Nude; Neuroblastoma; Receptor, trkB; Temozolomide; Topotecan; Xenograft Model Antitumor Assays | 2010 |
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.
Topics: Antineoplastic Agents; Brain Neoplasms; Carbazoles; Cell Line, Tumor; Drug Evaluation, Preclinical; Fenretinide; Furans; Humans; Isotretinoin; Neuroblastoma; Receptor, trkB | 2011 |